Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP KFPs / SAQsgastrointestinal-health

GP KFPs / SAQs · gastrointestinal-health

Constipation in adults — KFP-style written assessment

KFP-style staged scenarios on adult constipation: alarm-feature triage versus functional treatment, the diet-plus-laxative ladder with PEG and lactulose comparison, prucalopride escalation and secretagogue data, dyssynergia recognised and treated with biofeedback, opioid-induced constipation, and mood links.

30 marks45 min4 min readVerification in progress

Target exams

RACGP KFPRACGP AKTMRCGP AKT
On this page
Study tools

Target exams

RACGP KFPRACGP AKTMRCGP AKT
Prompt
Constipation: separating the serious from the stubborn — alarms, the laxative ladder, biofeedback and opioids

KFP 1 (10 marks)

A 47-year-old teacher presents with a two-year history of constipation: three bowel motions weekly, hard stools requiring straining, occasional incomplete evacuation. No bleeding, weight loss or anaemia. FBC, calcium, TSH normal. Diet poor in fibre; fluid intake low; desk-bound job.[10] [9]

  1. Does she meet Rome IV criteria? Justify. (3) [10]
  2. Prescribe the foundation treatment with specifics. (4) [9]
  3. She returns at six weeks partially improved. What is step two? (3) [5]

Model answers

  1. Yes: Rome IV requires at least two of straining in ≥25% of defecations, lumpy/hard Bristol 1-2 stools, blockage sensation, incompleteness, manual manoeuvres, fewer than three spontaneous bowel motions weekly — she meets straining, hard stools, and borderline frequency, with no IBS loose-stool pattern. [10]
  2. Foundation therapy per BDA guideline structure: soluble fibre supplement (e.g. psyllium) titrated slowly from ~5 g daily toward 20-30 g total daily fibre with adequate fluid to avoid gas and bloating; kiwifruit (two fruits daily) or prunes as evidence-supported food options; magnesium oxide as an additional evidence-backed supplement option; regular unhurried toilet time after breakfast exploiting the gastrocolic reflex; increased incidental exercise. The BDA guideline issued 59 statements covering fibre supplements, probiotics, magnesium oxide, kiwifruit supplements and foods including prunes and rye bread. [9]
  3. Add a first-line osmotic laxative: macrogol (PEG) one to three sachets daily titrated to effect. Randomised head-to-head comparison showed PEG produced faster therapeutic effect than lactulose at weeks one and two, though final effect was similar — PEG is preferred when speed matters. Review at four weeks; escalate only if optimised dosing fails. [5]
General Practice Pro

Continue reading

You have read the opening of this kfps / saq. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References10ShowHide
  1. [10]Youn JW, Joo H, Kim S et al. Global Prevalence of Functional Constipation Across All Age Groups According to Rome II-IV Criteria, 1999-2025: A Systematic Review and Meta-Analysis. Clinical and translational gastroenterology, 2026.PMID 41919745
  2. [9]Dimidi E, van der Schoot A, Barrett K et al. British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in Adults. Neurogastroenterology and motility, 2025.PMID 41081381
  3. [5]Li H, Zhang P, Xue Y A comparison of the safety and efficacy of polyethylene glycol 4000 and lactulose for the treatment of constipation in pregnant women: a randomized controlled clinical study. Annals of palliative medicine, 2020.PMID 33302648
  4. [2]Camilleri M, Piessevaux H, Yiannakou Y et al. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials. Digestive diseases and sciences, 2016.PMID 27056037
  5. [3]Black CJ, Burr NE, Quigley EMM et al. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis. Gastroenterology, 2018.PMID 30144426
  6. [12]Tu Y, Zhou Z, Li Y et al. Efficacy of biofeedback therapy for chronic constipation in adults: a systematic review and meta-analysis of randomized controlled trials. Frontiers in medicine, 2026.PMID 42292261
  7. [1]Chiarioni G, Heymen S, Whitehead WE Biofeedback therapy for dyssynergic defecation. World journal of gastroenterology, 2006.PMID 17131466
  8. [7]Portincasa P, Luglio CV, Sozzi S et al. Opioid-induced constipation in internal medicine: recognition and management pathways. Internal and emergency medicine, 2025.PMID 40877716
  9. [11]Ren ZY, Guo ZY, Diao Q et al. Constipation is associated with an increased risk of depression: A systematic review and meta-analysis of observational studies. Translational psychiatry, 2026.PMID 42230550
  10. [8]Preechakawin N, Maneerattanaporn M, Geeratragool T et al. Role of Prucalopride in the Treatment of Chronic Constipation in Parkinson Disease: A Randomized Controlled Trial. The American journal of gastroenterology, 2026.PMID 41002195
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousBowel cancer screening — KFP-style written assessmentgastrointestinal-healthNextDyspepsia, reflux, and Helicobacter pylori — KFP-style written assessmentgastrointestinal-health